Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash and Demand Deposits in the U.S.
QFR201385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
70,548.00
Year-over-Year Change
20.43%
Date Range
10/1/2000 - 1/1/2025
Summary
Captures cash and demand deposit levels for U.S. pharmaceutical and medicine corporations. Critical indicator of financial liquidity in the healthcare manufacturing sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
This quarterly financial metric tracks cash reserves for pharmaceutical companies. Provides insights into sector-wide financial capabilities and strategic positioning.
Methodology
Compiled through comprehensive corporate financial reporting and Federal Reserve surveys.
Historical Context
Utilized by investors, analysts, and policymakers to evaluate pharmaceutical industry financial health.
Key Facts
- Quarterly reporting frequency
- Includes U.S. bank deposits
- Reflects pharmaceutical sector financial strategy
FAQs
Q: What does this financial metric represent?
A: Shows total cash and demand deposits for U.S. pharmaceutical corporations. Indicates financial readiness and investment potential.
Q: How frequently is this data updated?
A: Reported quarterly, providing current insights into pharmaceutical company cash positions.
Q: Why is cash on hand crucial for pharmaceutical companies?
A: Enables research investment, drug development, and provides financial stability during market fluctuations.
Q: How can investors interpret this data?
A: Assess financial strength and potential for research, development, and strategic acquisitions in the pharmaceutical sector.
Q: What are the potential limitations of this metric?
A: Represents a specific point in time. Should be analyzed with other financial and industry indicators.
Related Trends
Quarterly Financial Report: U.S. Corporations: All Other Information: Current Portion of Long-Term Debt, Due in 1 Year or Less: Other Long-Term Loans
QFRD313519USNO
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326545USNO
Quarterly Financial Report: U.S. Corporations: Beverage and Tobacco Products: Net Property, Plant, and Equipment
QFR219312USNO
Quarterly Financial Report: U.S. Corporations: All Information: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102INFUSNO
Quarterly Financial Report: U.S. Corporations: All Retail Trade: Retained Earnings at End of Quarter
QFRD123RETUSNO
Quarterly Financial Report: U.S. Corporations: Telecommunications: Retained Earnings at End of Quarter
QFRD123517USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: Pharmaceuticals Corporations (QFR201385USNO), retrieved from FRED.